Skip to content
HowShorted

COLLEGIUM PHARMACEUTICAL, INC short interest in 2022

In 2022, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 9.81% of shares outstanding on 14 Jan 2022 to 10.91% on 30 Dec 2022, a change of +1.10 percentage points. The year's high was 11.71% on 15 Nov 2022 and its low 9.77% on 13 May 2022, averaging 10.60% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.18 days on 31 Oct 2022. Full history: COLLEGIUM PHARMACEUTICAL, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for COLLEGIUM PHARMACEUTICAL, INC in 2022

2022 in figures

Start of year
9.81% (14 Jan 2022)
End of year
10.91% (30 Dec 2022)
Change
+1.10 pp
High
11.71% (15 Nov 2022)
Low
9.77% (13 May 2022)
Average
10.60%
Highest days to cover
25.18 (31 Oct 2022)
SEC filings marked
8

Every report in 2022

COLLEGIUM PHARMACEUTICAL, INC short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20229.81%23.15
31 Jan 20229.91%14.54
15 Feb 202210.38%6.45
28 Feb 202210.84%5.7510-K filed, results (8-K)
15 Mar 202210.27%10.61
31 Mar 202210.24%10.25
14 Apr 202210.04%7.91
29 Apr 20229.96%9.25
13 May 20229.77%7.1910-Q filed, results (8-K)
31 May 202210.18%10.54
15 Jun 202210.91%13.56
30 Jun 202210.62%8.45
15 Jul 202210.37%13.03
29 Jul 202210.49%20.14
15 Aug 202210.80%13.8510-Q filed, results (8-K)
31 Aug 202210.60%19.92
15 Sep 202210.80%13.91
30 Sep 202211.15%14.79
14 Oct 202211.42%19.98
31 Oct 202211.43%25.18
15 Nov 202211.71%12.9510-Q filed, results (8-K)
30 Nov 202211.20%19.06
15 Dec 202210.69%15.52
30 Dec 202210.91%14.25

See also: COLLEGIUM PHARMACEUTICAL, INC's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.